Management of recurrent cervical cancer: the place of ultra-radical surgery
View/ Open
Date
1993-06Author
Rogo Khama O.
Stendahl, U
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
Although mortality from cervical cancer has decreased substantially the incidence of recurrent disease, at 35-50%, remains unaltered. Many more young patients are seen with recurrent cervical cancer today. This paper reviews this problem--its diagnosis and available modes of treatment. The place of re-irradiation, chemotherapy and ultra-radical surgery are discussed and their limitations highlighted. Better patient selection and individualised treatment planning are emphasised. Newer, more objective prognostic indicators based on molecular understanding of cancer cells are mentioned as hopeful means through which patient selection and treatment could be improved in the future. In the developing world where persistent or recurrent disease is more common, the situation is unlikely to improve soon
URI
http://www.ncbi.nlm.nih.gov/pubmed/8261961http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/29793
Citation
East Afr Med J. 1993 Jun;70(6):380-5Publisher
University of Nairobi. Department of Obstetrics and Gynaecology
Collections
- Faculty of Health Sciences (FHS) [10377]